Evaluation of HIV Infection in Febrile Patients Visiting Health Centers in Lagos, Nigeria

Overview

Journal BMC Res Notes

Publisher Biomed Central

Specialties Biology
General Medicine

Date 2022 Feb 20

PMID 35183247

Authors

Ololade O Akinnusi

Adebayo J Bello

Isaac A Adeleye

Jerry John Nutor

Affiliations

Soon will be listed here.

Abstract

Objective: Acute febrile infections compatible with malaria are the most prevalent presentation at sub-Saharan African health clinics, accounting for 30-50% of outpatient visits. Acute human immunodeficiency virus (HIV) infection can mimic acute malaria symptoms. As a result, screening people with malaria symptoms for HIV infection is critical. The goal of our study was to find out how common HIV infection was among feverish patients.

Results: Out of the 310 individuals screened, 9 (3.0%) had HIV-1 infection, with 5 (55.5%) being females and 4 (44.4%) being males. This study found no evidence of HIV-2 infection or HIV-1/HIV-2 co-infection. HIV infection was found in 1-3% of patients with probable malaria at different sites in Lagos, Nigeria.

Citing Articles

How Do People Living With HIV (PLHIV) and AIDS Feel About the Quality of Care They Received Amid the COVID-19 Pandemic in Lagos, Nigeria?.

Adeniran A, Shogbamimu Y, Ojo O, Chieme F, Olowofeso H, Sidebe I J Int Assoc Provid AIDS Care. 2023; 22:23259582231196708.

PMID: 37635327 PMC: 10467289. DOI: 10.1177/23259582231196708.

References

Abah R . The Demographic Implications of the HIV Prevalence Trend in Nigeria. J Public Health Afr. 2017; 5(1):277. PMC: 5345456. DOI: 10.4081/jphia.2014.277. View

Ezeanolue E, Obiefune M, Yang W, Obaro S, Ezeanolue C, Ogedegbe G . Comparative effectiveness of congregation- versus clinic-based approach to prevention of mother-to-child HIV transmission: study protocol for a cluster randomized controlled trial. Implement Sci. 2013; 8:62. PMC: 3700826. DOI: 10.1186/1748-5908-8-62. View

Brenner B, Roger M, Routy J, Moisi D, Ntemgwa M, Matte C . High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis. 2007; 195(7):951-9. DOI: 10.1086/512088. View

Pourhoseingholi M, Vahedi M, Rahimzadeh M . Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2014; 6(1):14-7. PMC: 4017493. View

Salawu O, Esume C . Frequency of Human Immunodeficiency Virus (HIV) in Trichomonas vaginalis Infected Women in Badagry, Lagos, Nigeria. J Reprod Infertil. 2016; 17(1):61-3. PMC: 4769857. View

Jallow S, Alabi A, Sarge-Njie R, Peterson K, Whittle H, Corrah T . Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants. J Clin Microbiol. 2009; 47(7):2200-8. PMC: 2708512. DOI: 10.1128/JCM.01654-08. View

Sanders E, Wahome E, Mwangome M, Thiongo A, Okuku H, Price M . Most adults seek urgent healthcare when acquiring HIV-1 and are frequently treated for malaria in coastal Kenya. AIDS. 2011; 25(9):1219-24. DOI: 10.1097/QAD.0b013e3283474ed5. View

Maiga M, Diarra B, Guindo A, Maiga Y, Fofano O, Bougoudogo F . [Seroprevalence of human immunodeficiency virus infection (HIV) in Mali on 3,496 sera]. Bull Soc Pathol Exot. 1993; 86(1):16-20. View

Motayo B, Faneye A, Udo U, Olusola B, Ezeani I, Ogiogwa J . Seroprevalence of transfusion transmissible infections (TTI), in first time blood donors in Abeokuta, Nigeria. Afr Health Sci. 2015; 15(1):19-24. PMC: 4370154. DOI: 10.4314/ahs.v15i1.3. View

10.

Prins H, Mugo P, Wahome E, Mwashigadi G, Thiongo A, Smith A . Diagnosing acute and prevalent HIV-1 infection in young African adults seeking care for fever: a systematic review and audit of current practice. Int Health. 2014; 6(2):82-92. PMC: 4049276. DOI: 10.1093/inthealth/ihu024. View

11.

Serna-Bolea C, Munoz J, Almeida J, Nhacolo A, Letang E, Nhampossa T . High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS. 2009; 24(4):603-8. DOI: 10.1097/QAD.0b013e328335cda3. View

12.

Zeh C, Pieniazek D, Agwale S, Robbins K, Odama L, Sani-Gwarzo N . Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections. AIDS Res Hum Retroviruses. 2005; 21(1):17-27. DOI: 10.1089/aid.2005.21.17. View

13.

Olaleye O, Bernstein L, Ekweozor C, Sheng Z, Omilabu S, Li X . Prevalence of human immunodeficiency virus types 1 and 2 infections in Nigeria. J Infect Dis. 1993; 167(3):710-4. DOI: 10.1093/infdis/167.3.710. View

14.

Nsagha D, Njunda A, Kamga H, Assob J, Bongkem E . HIV-1/HIV-2 co-infection among voluntary counselling and testing subjects at a regional hospital in Cameroon. Afr Health Sci. 2013; 12(3):276-81. PMC: 3557686. DOI: 10.4314/ahs.v12i3.5. View

15.

Alabi A, Jaffar S, Ariyoshi K, Blanchard T, Schim van der Loeff M, Awasana A . Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS. 2003; 17(10):1513-20. DOI: 10.1097/00002030-200307040-00012. View

16.

Bashorun A, Nguku P, Kawu I, Ngige E, Ogundiran A, Sabitu K . A description of HIV prevalence trends in Nigeria from 2001 to 2010: what is the progress, where is the problem?. Pan Afr Med J. 2014; 18 Suppl 1:3. PMC: 4199354. DOI: 10.11694/pamj.supp.2014.18.1.4608. View

17.

Lindback S, Thorstensson R, Karlsson A, von Sydow M, Flamholc L, Blaxhult A . Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS. 2000; 14(15):2333-9. DOI: 10.1097/00002030-200010200-00014. View